Announcement Archives

Announcement

Certara Expands the Simcyp™ Simulator Platform Advancing Biologics and Biopharmaceutics Capabilities

Updates advance the mission of the FDA’s new Quantitative Medicine Center of Excellence, which seeks…

CertaraJune 3, 2024

Announcement

Pinnacle 21 Releases P21 Community 4.1.0

Release Date: May 31, 2024 P21 Community 4.1.0 is now available! Download the latest version. This release…

CertaraMay 31, 2024

Announcement

CERTARA & CLOUDSCIENTIFIC ACCELERATE AI FOR DRUG DEVELOPMENT IN CHINA

Partnership will provide biopharmaceutical companies with advanced tools and solutions needed to expedite research …

CertaraMay 10, 2024

Announcement

Pinnacle 21 Releases New PMDA, FDA, NMPA Validation Engines

Pinnacle 21 by Certara announces the latest Validation Engines for submissions to Japan PMDA, US…

CertaraApril 23, 2024

Announcement

Certara Announces Inaugural Client Conference with Keynote by Dr. Scott Gottlieb

Agenda features discussion of life sciences industry trends, business value of model-informed drug development strategies,…

CertaraApril 18, 2024

Announcement

Certara Announces New Corporate Headquarters

New, spacious location in Radnor, Pennsylvania will support the needs of company’s growing workforce and…

CertaraApril 15, 2024

Announcement

Certara Launches Updated Version of Pirana Modeling Workbench

PRINCETON, N.J.— December 1, 2023 – Certara, Inc., a global leader in biosimulation, today announced…

CertaraDecember 1, 2023

Announcement

Certara Recognized as 2023 Employer of Choice

PRINCETON, N.J.— November 1 2023, Certara (Nasdaq: CERT), a global leader in biosimulation, today announced…

CertaraNovember 1, 2023

Announcement

Certara Acquires Formedix LLC to Increase Data Standardization Across Clinical Trials for Faster Study Setup, Time to Analysis and Submissions

Formedix ryze cloud based clinical metadata repository and SDTM automation suite and Certara Pinnacle 21…

CertaraOctober 10, 2023

Announcement

Certara Introduces Certara.AI, the Life Sciences Specialized GPT Platform

Certara.AI Improves Drug Research & Development Processes with Secure, Client-Specific, A.I. Applications PRINCETON, N. J.—October…

CertaraOctober 5, 2023

Announcement

Certara Expands the Simcyp™ Simulator Platform Advancing Biologics and Biopharmaceutics Capabilities

Pinnacle 21 Releases P21 Community 4.1.0

CERTARA & CLOUDSCIENTIFIC ACCELERATE AI FOR DRUG DEVELOPMENT IN CHINA

Pinnacle 21 Releases New PMDA, FDA, NMPA Validation Engines

Certara Announces Inaugural Client Conference with Keynote by Dr. Scott Gottlieb

Certara Announces New Corporate Headquarters

Certara Launches Updated Version of Pirana Modeling Workbench

Certara Recognized as 2023 Employer of Choice

Certara Acquires Formedix LLC to Increase Data Standardization Across Clinical Trials for Faster Study Setup, Time to Analysis and Submissions

Certara Introduces Certara.AI, the Life Sciences Specialized GPT Platform

Newsletter sign up

Quick links

Solutions

Contact